Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Jan;67(1):142–150.

Immunological reconstitution after bone marrow transplant with Campath-1 treated bone marrow.

A Parreira, J Smith, J M Hows, S A Smithers, J Apperley, Y Rombos, J M Goldman, E C Gordon-Smith, D Catovsky
PMCID: PMC1542574  PMID: 3304736

Abstract

Immunological reconstitution after allogeneic bone marrow transplant (BMT) was studied in 20 patients who received Campath-1 treated bone marrow. The peripheral blood lymphocyte phenotype was analysed with a panel of monoclonal antibodies at 3, 6 and 12 months. T cell proliferative capacity was evaluated by stimulation with PHA and Con A and in the mixed lymphocyte reaction (MLR). Natural killer (NK) cell activity was analysed against the K562 cell line at specified times after BMT in nine patients. Absolute numbers of T lymphocytes were reduced in all patients at 3 and 6 months. A marked decrease in the number of CD4+ cells persisted beyond 12 months. CD8+ cells regenerated more rapidly and reached normal at 6 months. No correlation was found between changes in lymphocyte subpopulations and the presence of graft-versus-host disease or cytomegalovirus infection. B cells recovered rapidly and maintained normal numbers throughout the study. A moderate increase in HNK1+ (Leu7) cells was observed at 3 and 6 months simultaneously with a low expression of NK15 (Leu11) and OKM1 antigens at 3 and 6 months, suggesting the presence of immature NK cells early after the transplant. A profound decrease of T cell proliferative capacity was observed both after mitogen stimulation and in the mixed lymphocyte reaction. NK cell activity was raised during the first month after transplant in all but one patient but no correlation was found with the presence of GVHD or cell marker analysis.

Full text

PDF
142

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo T., Miller C. A., Gartland G. L., Balch C. M. Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J Exp Med. 1983 Jan 1;157(1):273–284. doi: 10.1084/jem.157.1.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atkinson K., Hansen J. A., Storb R., Goehle S., Goldstein G., Thomas E. D. T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood. 1982 Jun;59(6):1292–1298. [PubMed] [Google Scholar]
  3. Elfenbein G. J., Ashkenazi Y. J., Barth K. C. Further phenotypic characterization of T cells after human allogeneic bone marrow transplantation. Transplantation. 1985 Jan;39(1):97–102. [PubMed] [Google Scholar]
  4. Favrot M., Janossy G., Tidman N., Blacklock H., Lopez E., Bofill M., Lampert I., Morgenstein G., Powles R., Prentice H. G. T cell regeneration after allogeneic bone marrow transplantation. Clin Exp Immunol. 1983 Oct;54(1):59–72. [PMC free article] [PubMed] [Google Scholar]
  5. Fox R., McMillan R., Spruce W., Tani P., Mason D. Analysis of T lymphocytes after bone marrow transplantation using monoclonal antibodies. Blood. 1982 Sep;60(3):578–582. [PubMed] [Google Scholar]
  6. Ginsburg D., Antin J. H., Smith B. R., Orkin S. H., Rappeport J. M. Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphisms. J Clin Invest. 1985 Feb;75(2):596–603. doi: 10.1172/JCI111736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Glucksberg H., Storb R., Fefer A., Buckner C. D., Neiman P. E., Clift R. A., Lerner K. G., Thomas E. D. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974 Oct;18(4):295–304. doi: 10.1097/00007890-197410000-00001. [DOI] [PubMed] [Google Scholar]
  8. Gratama J. W., Würsch A. M., Nissen C., Gratwohl A., D'Amaro J., de Gast G. C., van Rood J. J., Speck B. Influence of graft-versus-host disease prophylaxis on early T-lymphocyte regeneration following allogeneic bone marrow transplantation. Br J Haematol. 1986 Feb;62(2):355–365. doi: 10.1111/j.1365-2141.1986.tb02939.x. [DOI] [PubMed] [Google Scholar]
  9. Hale G., Bright S., Chumbley G., Hoang T., Metcalf D., Munro A. J., Waldmann H. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood. 1983 Oct;62(4):873–882. [PubMed] [Google Scholar]
  10. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  11. Hows J., Beddow K., Gordon-Smith E., Branch D. R., Spruce W., Sniecinski I., Krance R. A., Petz L. D. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood. 1986 Jan;67(1):177–181. [PubMed] [Google Scholar]
  12. Janossy G., Prentice H. G., Grob J. P., Ivory K., Tidman N., Grundy J., Favrot M., Brenner M. K., Campana D., Blacklock H. A. T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow. Clin Exp Immunol. 1986 Mar;63(3):577–586. [PMC free article] [PubMed] [Google Scholar]
  13. Kay H. D., Horwitz D. A. Evidence by reactivity with hybridoma antibodies for a probable myeloid origin of peripheral blood cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Clin Invest. 1980 Oct;66(4):847–851. doi: 10.1172/JCI109923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lanier L. L., Le A. M., Phillips J. H., Warner N. L., Babcock G. F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol. 1983 Oct;131(4):1789–1796. [PubMed] [Google Scholar]
  15. Matutes E., Parreira A., Foa R., Catovsky D. Monoclonal antibody OKT17 recognizes most cases of T-cell malignancy. Br J Haematol. 1985 Dec;61(4):649–656. doi: 10.1111/j.1365-2141.1985.tb02879.x. [DOI] [PubMed] [Google Scholar]
  16. Prentice H. G., Blacklock H. A., Janossy G., Gilmore M. J., Price-Jones L., Tidman N., Trejdosiewicz L. K., Skeggs D. B., Panjwani D., Ball S. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet. 1984 Mar 3;1(8375):472–476. doi: 10.1016/s0140-6736(84)92848-4. [DOI] [PubMed] [Google Scholar]
  17. Pross H. F., Baines M. G., Rubin P., Shragge P., Patterson M. S. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol. 1981 Jan;1(1):51–63. doi: 10.1007/BF00915477. [DOI] [PubMed] [Google Scholar]
  18. Schroff R. W., Gale R. P., Fahey J. L. Regeneration of T cell subpopulations after bone marrow transplantation: cytomegalovirus infection and lymphoid subset imbalance. J Immunol. 1982 Nov;129(5):1926–1930. [PubMed] [Google Scholar]
  19. Sullivan K. M., Parkman R. The pathophysiology and treatment of graft-versus-host disease. Clin Haematol. 1983 Oct;12(3):775–789. doi: 10.1016/s0308-2261(83)80010-1. [DOI] [PubMed] [Google Scholar]
  20. Würsch A. M., Gratama J. W., Middeldorp J. M., Nissen C., Gratwohl A., Speck B., Jansen J., D'Amaro J., The T. H., De Gast G. C. The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. Clin Exp Immunol. 1985 Nov;62(2):278–287. [PMC free article] [PubMed] [Google Scholar]
  21. Yamada S., Yanagisawa M., Miyagawa Y., Komiyama A., Akabane T. Prompt reconstitution of natural killer cells after bone marrow transplantation. Nihon Ketsueki Gakkai Zasshi. 1985 Sep;48(6):1451–1458. [PubMed] [Google Scholar]
  22. de Bruin H. G., Astaldi A., Leupers T., van de Griend R. J., Dooren L. J., Schellekens P. T., Tanke H. J., Roos M., Vossen J. M. T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies. J Immunol. 1981 Jul;127(1):244–251. [PubMed] [Google Scholar]
  23. de Gast G. C., Verdonck L. F., Middeldorp J. M., The T. H., Hekker A., vd Linden J. A., Kreeft H. A., Bast B. J. Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft. Blood. 1985 Aug;66(2):428–431. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES